Ferroptosis in colorectal cancer: Molecular mechanisms and regulatory crosstalk with therapeutic prospects (Review)

Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I and Jemal A: Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 74:229–263. 2024.PubMed/NCBI

Dekker E, Tanis PJ, Vleugels JLA, Kasi PM and Wallace MB: Colorectal cancer. Lancet. 394:1467–1480. 2019. View Article : Google Scholar : PubMed/NCBI

Morris VK, Kennedy EB, Baxter NN, Benson AB III, Cercek A, Cho M, Ciombor KK, Cremolini C, Davis A, Deming DA, et al: Treatment of metastatic colorectal cancer: ASCO guideline. J Clin Oncol. 41:678–700. 2023. View Article : Google Scholar : PubMed/NCBI

Siegel RL, Miller KD, Goding Sauer A, Fedewa SA, Butterly LF, Anderson JC, Cercek A, Smith RA and Jemal A: Colorectal cancer statistics, 2020. CA Cancer J Clin. 70:145–164. 2020.PubMed/NCBI

Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS, et al: Ferroptosis: An iron-dependent form of nonapoptotic cell death. Cell. 149:1060–1072. 2012. View Article : Google Scholar : PubMed/NCBI

Wu A, Ni Y, Zhou Y and Shi J: Emerging dual role of ferroptosis in lung cancer (Review). Oncol Rep. 54:1412025. View Article : Google Scholar : PubMed/NCBI

Liu Y, Lu S, Wu LL, Yang L, Yang L and Wang J: The diversified role of mitochondria in ferroptosis in cancer. Cell Death Dis. 14:5192023. View Article : Google Scholar : PubMed/NCBI

Dixon SJ and Olzmann JA: The cell biology of ferroptosis. Nat Rev Mol Cell Bio. 25:424–442. 2024. View Article : Google Scholar : PubMed/NCBI

Wang S, Guo Q, Zhou L and Xia X: Ferroptosis: A double-edged sword. Cell Death Discov. 10:2652024. View Article : Google Scholar : PubMed/NCBI

Masci D, Ling L, Yang L, Puxeddu M, Colla C, Coluccia A, Santelli M, Sciò P, Cuřínová P, Ansari MSZ, et al: Ferroptosis induction by a new pyrrole derivative in triple negative breast cancer and colorectal cancer. J Med Chem. 68:17840–17858. 2025. View Article : Google Scholar : PubMed/NCBI

Xia W, Lv Y, Zou Y, Kang Z, Li Z, Tian J, Zhou H, Su W and Zhong J: The role of ferroptosis in colorectal cancer and its potential synergy with immunotherapy. Front Immunol. 15:15267492025. View Article : Google Scholar : PubMed/NCBI

Neagu AI, Bostan M, Ionescu VA, Gheorghe G, Hotnog CM, Roman V, Mihaila M, Stoica SI, Diaconu CC, Diaconu CC, et al: The impact of the microbiota on the immune response modulation in colorectal cancer. Biomolecules. 15:10052025. View Article : Google Scholar : PubMed/NCBI

Liu K, Huang L, Qi S, Liu S, Xie W, Du L, Cui J, Zhang X, Zhang B, Liu L, et al: Ferroptosis: The Entanglement between Traditional drugs and nanodrugs in tumor therapy. Adv Healthc Mater. 12:e22030852023. View Article : Google Scholar : PubMed/NCBI

Schmitt M and Greten FR: The inflammatory pathogenesis of colorectal cancer. Nat Rev Immunol. 21:653–667. 2021. View Article : Google Scholar : PubMed/NCBI

Xie H, Cao C, Shu D, Liu T and Zhang T: The important role of ferroptosis in inflammatory bowel disease. Front Med (Lausanne). 11:14490372024. View Article : Google Scholar : PubMed/NCBI

Mouawad N, El Jaafari N, El Sibai M and Abi-Habib RJ: Harnessing ferroptosis for cancer therapy: Mechanisms and therapeutic strategies (Review). Oncol Rep. 55:242026.PubMed/NCBI

Ding K, Liu C, Li L, Yang M, Jiang N, Luo S and Sun L: Acyl-CoA synthase ACSL4: An essential target in ferroptosis and fatty acid metabolism. Chin Med J (Engl). 136:2521–2537. 2023. View Article : Google Scholar : PubMed/NCBI

Lee JY, Kim WK, Bae KH, Lee SC and Lee EW: Lipid metabolism and ferroptosis. Biology (Basel). 10:1842021.PubMed/NCBI

Gündem E, Stehling S, Borchert A and Kuhn H: The reaction specificity of mammalian ALOX15B orthologs does not depend on the evolutionary ranking of the animals. J Lipid Res. 66:1007682025. View Article : Google Scholar : PubMed/NCBI

Dai E, Chen X, Linkermann A, Jiang X, Kang R, Kagan VE, Bayir H, Yang WS, Garcia-Saez AJ, Ioannou MS, et al: A guideline on the molecular ecosystem regulating ferroptosis. Nat Cell Biol. 26:1447–1457. 2024. View Article : Google Scholar : PubMed/NCBI

Tesfay L, Paul BT, Konstorum A, Deng Z, Cox AO, Lee J, Furdui CM, Hegde P, Torti FM and Torti SV: Stearoyl-CoA Desaturase 1 protects ovarian cancer cells from ferroptotic cell death. Cancer Res. 79:5355–5366. 2019. View Article : Google Scholar : PubMed/NCBI

Rodencal J, Kim N, He A, Li VL, Lange M, He J, Tarangelo A, Schafer ZT, Olzmann JA, Long JZ, et al: Sensitization of cancer cells to ferroptosis coincident with cell cycle arrest. Cell Chem Biol. 31:234–248.e13. 2024. View Article : Google Scholar : PubMed/NCBI

Liang D, Feng Y, Zandkarimi F, Wang H, Zhang Z, Kim J, Cai Y, Gu W, Stockwell BR and Jiang X: Ferroptosis surveillance independent of GPX4 and differentially regulated by sex hormones. Cell. 186:2748–2764.e22. 2023. View Article : Google Scholar : PubMed/NCBI

Sokol KH, Lee CJ, Rogers TJ, Waldhart A, Ellis AE, Madireddy S, Daniels SR, House RRJ, Ye X, Olesnavich M, et al: Lipid availability influences ferroptosis sensitivity in cancer cells by regulating polyunsaturated fatty acid trafficking. Cell Chem Biol. 32:408–422.e6. 2025. View Article : Google Scholar : PubMed/NCBI

Feng H, Schorpp K, Jin J, Yozwiak CE, Hoffstrom BG, Decker AM, Rajbhandari P, Stokes ME, Bender HG, Csuka JM, et al: Transferrin receptor is a specific ferroptosis marker. Cell Rep. 30:3411–3423.e7. 2020. View Article : Google Scholar : PubMed/NCBI

Liu D, Hu Z, Lu J and Yi C: Redox-regulated iron metabolism and ferroptosis in ovarian cancer: Molecular insights and therapeutic opportunities. Antioxidants (Basel). 13:7912024. View Article : Google Scholar : PubMed/NCBI

Shi J, Yang MM, Yang S, Fan F, Zheng G, Miao Y, Hua Y, Zhang J, Cheng Y, Liu S, et al: MaiJiTong granule attenuates atherosclerosis by reducing ferroptosis via activating STAT6-mediated inhibition of DMT1 and SOCS1/p53 pathways in LDLR-/- mice. Phytomedicine. 128:1554892024. View Article : Google Scholar : PubMed/NCBI

Brown CW, Amante JJ, Chhoy P, Elaimy AL, Liu H, Zhu LJ, Baer CE, Dixon SJ and Mercurio AM: Prominin2 drives ferroptosis resistance by stimulating iron export. Dev Cell. 51:575–586.e4. 2019. View Article : Google Scholar : PubMed/NCBI

Katsarou A and Pantopoulos K: Basics and principles of cellular and systemic iron homeostasis. Mol Aspects Med. 75:1008662020. View Article : Google Scholar : PubMed/NCBI

Mancias JD, Wang X, Gygi SP, Harper JW and Kimmelman AC: Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy. Nature. 509:105–109. 2014. View Article : Google Scholar : PubMed/NCBI

Liu L, Liu Y, Zhou X, He H, Chen N, Qin Y, Sun X, Bian Z, Zhang Q, Mao L and Sun S: Sodium butyrate induces ferroptosis in colorectal cancer cells by promoting NCOA4-FTH1-mediated ferritinophagy. Int Immunopharmacol. 163:1151882025. View Article : Google Scholar : PubMed/NCBI

Jin B, Zhang Z, Zhang Y, Yang M, Wang C, Xu J, Zhu Y, Mi Y, Jiang J and Sun Z: Ferroptosis and myocardial ischemia-reperfusion: Mechanistic insights and new therapeutic perspectives. Front Pharmacol. 15:14829862024. View Article : Google Scholar : PubMed/NCBI

Kunji ERS, King MS, Ruprecht JJ and Thangaratnarajah C: The SLC25 carrier family: Important transport proteins in mitochondrial physiology and pathology. Physiology (Bethesda). 35:302–327. 2020.PubMed/NCBI

She G, Hai XX, Jia LY, Zhang YJ, Ren YJ, Pang ZD, Wu LH, Han MZ, Zhang Y, Li JJ, et al: Hippo pathway activation mediates cardiomyocyte ferroptosis to promote dilated cardiomyopathy through downregulating NFS1. Redox Biol. 82:1035972025. View Article : Google Scholar : PubMed/NCBI

Song Y, Gao M, Wei B, Huang X, Yang Z, Zou J and Guo Y: Mitochondrial ferritin alleviates ferroptosis in a kainic acid-induced mouse epilepsy model by regulating iron homeostasis: Involvement of nuclear factor erythroid 2-related factor 2. CNS Neurosci Ther. 30:e146632024. View Article : Google Scholar : PubMed/NCBI

Banerjee R, Bintee B, Hegde M, BharathwajChetty B, Alqahtani MS, Abbas M, Alqahtani A, Sethi G, Rangan L, Ma Z and Kunnumakkara AB: Protein iron transporters as potential therapeutic targets in cancer: A review. Int J Biol Macromol. 327((Pt 2)): 1466952025. View Article : Google Scholar : PubMed/NCBI

Bai S, Guo Y, Qiang J, Dai Q and Yang Y: Research progress on the regulation of ferroptosis in NPC (Review). Oncol Rep. 55:332026.PubMed/NCBI

Zhao C, Huang X, Wu Z, Sun W, Pan Y and Liu Y: pH-Responsive self-assembled upconversion photosensitizer and RSL3 synergistically induce tumor ferroptosis. J Med Chem. 68:15110–15119. 2025. View Article : Google Scholar : PubMed/NCBI

Tang D, Chen X, Kang R and Kroemer G: Ferroptosis: Molecular mechanisms and health implications. Cell Res. 31:107–125. 2021. View Article : Google Scholar : PubMed/NCBI

Yang WS, SriRamaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS, Cheah JH, Clemons PA, Shamji AF, Clish CB, et al: Regulation of ferroptotic cancer cell death by GPX4. Cell. 156:317–331. 2014. View Article : Google Scholar : PubMed/NCBI

Song X, Hao X and Zhu BT: Role of mitochondrial reactive oxygen species in chemically-induced ferroptosis. Free Radical Biol Med. 223:473–492. 2024. View Article : Google Scholar : PubMed/NCBI

Lee J and Roh JL: Selenium and selenoproteins: Key regulators of ferroptosis and therapeutic targets in cancer. J Mol Med (Berl). 103:899–911. 2025. View Article : Google Scholar : PubMed/NCBI

Gao R, Wang J, Huang J, Wang T, Guo L, Liu W, Guan J, Liang D, Meng Q and Pan H: FSP1-mediated ferroptosis in cancer: from mechanisms to therapeutic applications. Apoptosis. 29:1019–1037. 2024. View Article : Google Scholar : PubMed/NCBI

Yang JS, Morris AJ, Kamizaki K, Chen J, Stark J, Oldham WM, Nakamura T, Mishima E, Loscalzo J, Minami Y, et al: ALDH7A1 protects against ferroptosis by generating membrane NADH and regulating FSP1. Cell. 188:2569–2585.e20. 2025. View Article : Google Scholar : PubMed/NCBI

Li W, Liang L, Liu S, Yi H and Zhou Y: FSP1: A key regulator of ferroptosis. Trends Mol Med. 29:753–764. 2023. View Article : Google Scholar : PubMed/NCBI

Mao C, Liu X, Zhang Y, Lei G, Yan Y, Lee H, Koppula P, Wu S, Zhuang L, Fang B, et al: DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer. Nature. 593:586–590. 2021. View Article : Google Scholar : PubMed/NCBI

Deshwal S, Onishi M, Tatsuta T, Bartsch T, Cors E, Ried K, Lemke K, Nolte H, Giavalisco P and Langer T: Mitochondria regulate intracellular coenzyme Q transport and ferroptotic resistance via STARD7. Nat Cell Biol. 25:246–257. 2023.PubMed/NCBI

Liu Z, Kang R, Yang N, Pan X, Yang J, Yu H, Deng W, Jia Z, Zhang J and Shen Q: Tetrahydrobiopterin inhibitor-based antioxidant metabolic strategy for enhanced cancer ferroptosis-immunotherapy. J Colloid Interf Sci. 658:100–113. 2024. View Article : Google Scholar : PubMed/NCBI

Du J, Zhu X, Zhang Y, Huang X, Wang X, Yang F, Xia H and Hou J: CTRP13 attenuates atherosclerosis by inhibiting endothelial cell ferroptosis via activating GCH1. Int Immunopharmacol. 143((Pt 3)): 1136172024. View Article : Google Scholar : PubMed/NCBI

Liu Y and Gu W: p53 in ferroptosis regulation: The new weapon for the old guardian. Cell Death Differ. 29:895–910. 2022. View Article : Google Scholar : PubMed/NCBI

Jiang L, Kon N, Li T, Wang SJ, Su T, Hibshoosh H, Baer R and Gu W: Ferroptosis as a p53-mediated activity during tumour suppression. Nature. 520:57–62. 2015. View Article : Google Scholar : PubMed/NCBI

Chu B, Kon N, Chen D, Li T, Liu T, Jiang L, Song S, Tavana O and Gu W: ALOX12 is required for p53-mediated tumour suppression through a distinct ferroptosis pathway. Nat Cell Biol. 21:579–591. 2019. View Article : Google Scholar : PubMed/NCBI

Chen L, Cai Q, Yang R, Wang H, Ling H, Li T, Liu N, Wang Z, Sun J, Tao T, et al: GINS4 suppresses ferroptosis by antagonizing p53 acetylation with Snail. Proc Natl Acad Sci USA. 120:e22195851202023. View Article : Google Scholar : PubMed/NCBI

Zhang Y, Song XW, Zhang N, Li XH, Wu FC, Wei YA, Xu DL, Xu LF and Yuan FW: Ezetimibe engineered L14-8 suppresses advanced prostate cancer by activating PLK1/TP53-SAT1 -induced ferroptosis. Adv Sci (Weinh). 12:e041922025. View Article : Google Scholar : PubMed/NCBI

Shin D, Lee J and Roh J: Pioneering the future of cancer therapy: Deciphering the p53-ferroptosis nexus for precision medicine. Cancer Lett. 585:2166452024. View Article : Google Scholar : PubMed/NCBI

Tarangelo A, Magtanong L, Bieging-Rolett KT, Li Y, Ye J, Attardi LD and Dixon SJ: p53 suppresses metabolic stress-induced ferroptosis in cancer cells. Cell Rep. 22:569–575. 2018. View Article : Google Scholar : PubMed/NCBI

Xie Y, Zhu S, Song X, Sun X, Fan Y, Liu J, Zhong M, Yuan H, Zhang L, Billiar TR, et al: The tumor suppressor p53 limits ferroptosis by blocking DPP4 activity. Cell Rep. 20:1692–1704. 2017. View Article : Google Scholar : PubMed/NCBI

Yang X, Liang B, Zhang L, Zhang M, Ma M, Qing L, Yang H, Huang G and Zhao J: Ursolic acid inhibits the proliferation of triple-negative breast cancer stem-like cells through NRF2-mediated ferroptosis. Oncol Rep. 52:942024. View Article : Google Scholar : PubMed/NCBI

Jiang X, Yu M, Wang WK, Zhu LY, Wang X, Jin HC and Feng LF: The regulation and function of Nrf2 signaling in ferroptosis-activated cancer therapy. Acta Pharmacol Sin. 45:2229–2240. 2024. View Article : Google Scholar : PubMed/NCBI

Chen Y, Jiang Z and Li X: New insights into crosstalk between Nrf2 pathway and ferroptosis in lung disease. Cell Death Dis. 15:8412024. View Article : Google Scholar : PubMed/NCBI

Xiang Y, Song X and Long D: Ferroptosis regulation through Nrf2 and implications for neurodegenerative diseases. Arch Toxicol. 98:579–615. 2024. View Article : Google Scholar : PubMed/NCBI

Bollong MJ, Lee G, Coukos JS, Yun H, Zambaldo C, Chang JW, Chin EN, Ahmad I, Chatterjee AK, Lairson LL, et al: A metabolite-derived protein modification integrates glycolysis with KEAP1-NRF2 signalling. Nature. 562:600–604. 2018. View Article : Google Scholar : PubMed/NCBI

Huang C, Zeng Q, Chen J, Wen Q, Jin W, Dai X, Ruan R, Zhong H, Xia Y, Wu Z, et al: TMEM160 inhibits KEAP1 to suppress ferroptosis and induce chemoresistance in gastric cancer. Cell Death Dis. 16:2872025. View Article : Google Scholar : PubMed/NCBI

Wang S, Zhang C, Zhou S, Liu S, Li Q, Cheng X, Wang R, Chen B, Li Y and Xi M: RNF217-KEAP1-NRF2 feedback loop confers therapeutic resistance by inhibiting ferroptosis in esophageal squamous cell carcinoma. Drug Resist Update. 83:1012962025. View Article : Google Scholar : PubMed/NCBI

Xu RC, Sun JL, Wang F, Liu HH, Qi ZR, Shi X, Yu XN, Liu TT, Weng SQ, Dong L, et al: Cathepsin S regulates ferroptosis sensitivity in hepatocellular carcinoma through the KEAP1-NRF2 signaling pathway. Redox Biol. 86:1038152025. View Article : Google Scholar : PubMed/NCBI

Chang K, Chen Y, Zhang X, Zhang W, Xu N, Zeng B, Wang Y, Feng T, Dai B, Xu F, et al: DPP9 stabilizes NRF2 to suppress ferroptosis and induce sorafenib resistance in clear cell renal cell carcinoma. Cancer Res. 83:3940–3955. 2023. View Article : Google Scholar : PubMed/NCBI

Wang Z, Li R, Hou N, Zhang J, Wang T, Fan P, Ji C, Zhang B, Liu L, Wang Y, et al: PRMT5 reduces immunotherapy efficacy in triple-negative breast cancer by methylating KEAP1 and inhibiting ferroptosis. J Immunother Cancer. 11:e0068902023. View Article : Google Scholar : PubMed/NCBI

Li S, Huang P, Lai F, Zhang T, Guan J, Wan H and He Y: Mechanisms of ferritinophagy and ferroptosis in diseases. Mol Neurobiol. 61:1605–1626. 2024. View Article : Google Scholar : PubMed/NCBI

Wu H, Liu Q, Shan X, Gao W and Chen Q: ATM orchestrates ferritinophagy and ferroptosis by phosphorylating NCOA4. Autophagy. 19:2062–2077. 2023. View Article : Google Scholar : PubMed/NCBI

Wang H, Zhang P, Cheng Q, Chang K, Bao L and Yi X: Heme oxygenase-1 (HO-1) depletion promotes ferroptosis to reverse cisplatin-resistance via enhancing NCOA4-mediated ferritinophagy in ovarian cancer. Int J Biol Macromol. 327:1472572025. View Article : Google Scholar : PubMed/NCBI

Liu Z, Liu C, Fan C, Li R, Zhang S, Liu J, Li B, Zhang S, Guo L, Wang X, et al: E3 ubiquitin ligase DTX2 fosters ferroptosis resistance via suppressing NCOA4-mediated ferritinophagy in non-small cell lung cancer. Drug Resist Update. 77:1011542024. View Article : Google Scholar : PubMed/NCBI

Zhang Q, Xu Z, Liu W, Cheng Z, Ding Y, Xie Y and Yan S: Gastrodin promotes ferroptosis in CRC cells by inhibiting SKP2 to reduce NCOA4 ubiquitination. Tissue Cell. 95:1027932025. View Article : Google Scholar : PubMed/NCBI

Shen C, Liu J, Liu H, Li G, Wang H, Tian H, Mao Y and Hua D: Timosaponin AIII induces lipid peroxidation and ferroptosis by enhancing Rab7-mediated lipophagy in colorectal cancer cells. Phytomedicine. 122:1550792024. View Article : Google Scholar : PubMed/NCBI

Gnanapradeepan K, Indeglia A, Stieg DC, Clarke N, Shao C, Dougherty JF, Murali N and Murphy ME: PLTP is a p53 target gene with roles in cancer growth suppression and ferroptosis. J Biol Chem. 298:1026372022. View Article : Google Scholar : PubMed/NCBI

Yang M, Chen P, Liu J, Zhu S, Kroemer G, Klionsky DJ, Lotze MT, Zeh HJ, Kang R and Tang D: Clockophagy is a novel selective autophagy process favoring ferroptosis. Sci Adv. 5:eaaw22382019. View Article : Google Scholar : PubMed/NCBI

Jiang H, Wang X, Zhu Z, Song C, Li D, Yun Y, Hui L, Bao L, O Connor DP, Ma J and Xu G: DCAF7 recruits USP2 to facilitate hepatocellular carcinoma progression by suppressing clockophagy-induced ferroptosis. Cell Death Dis. 16:6542025. View Article : Google Scholar : PubMed/NCBI

Granata S, Votrico V, Spadaccino F, Catalano V, Netti GS, Ranieri E, Stallone G and Zaza G: Oxidative stress and ischemia/reperfusion injury in kidney transplantation: Focus on ferroptosis, mitophagy and new antioxidants. Antioxidants (Basel). 11:7692022. View Article : Google Scholar : PubMed/NCBI

Liu S, Chen JH, Li LC, Ye ZP, Liu JN, Chen YH, Hu BX, Tang JH, Feng GK, Li ZM, et al: Susceptibility of mitophagy-deficient tumors to ferroptosis induction by relieving the suppression of lipid peroxidation. Adv Sci (Weinh). 12:e24125932025. View Article : Google Scholar : PubMed/NCBI

Yu S, Li Z, Zhang Q, Wang R, Zhao Z, Ding W, Wang F, Sun C, Tang J, Wang X, et al: GPX4 degradation via chaperone-mediated autophagy contributes to antimony-triggered neuronal ferroptosis. Ecotoxicol Environ Saf. 234:1134132022. View Article : Google Scholar : PubMed/NCBI

Wu Z, Geng Y, Lu X, Shi Y, Wu G, Zhang M, Shan B, Pan H and Yuan J: Chaperone-mediated autophagy is involved in the execution of ferroptosis. Proc Natl Acad Sci USA. 116:2996–3005. 2019. View Article : Google Scholar : PubMed/NCBI

Chen J, Peng Y, Zhou M, Che Y, Zhao S, He C, Zhang W, Tian X, Zhang W, Liu Z, et al: P23 acts as a negative regulator of ferroptosis in NSCLC by blocking GPX4 degradation via chaperone-mediated autophagy. Mol Cancer. 24:2342025. View Article : Google Scholar : PubMed/NCBI

Wu K, Yan M, Liu T, Wang Z, Duan Y, Xia Y, Ji G, Shen Y, Wang L, Li L, et al: Creatine kinase B suppresses ferroptosis by phosphorylating GPX4 through a moonlighting function. Nat Cell Biol. 25:714–725. 2023. View Article : Google Scholar : PubMed/NCBI

Lei G, Zhuang L and Gan B: The roles of ferroptosis in cancer: Tumor suppression, tumor microenvironment, and therapeutic interventions. Cancer Cell. 42:513–534. 2024. View Article : Google Scholar : PubMed/NCBI

Wang W, Green M, Choi JE, Gijón M, Kennedy PD, Johnson JK, Liao P, Lang X, Kryczek I, Sell A, et al: CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy. Nature. 569:270–274. 2019. View Article : Google Scholar : PubMed/NCBI

Liao P, Wang W, Wang W, Kryczek I, Li X, Bian Y, Sell A, Wei S, Grove S, Johnson JK, et al: CD8+ T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4. Cancer Cell. 40:365–378.e6. 2022. View Article : Google Scholar : PubMed/NCBI

Jiang Y, Li J, Wang T, Gu X, Li X, Liu Z, Yue W and Li M: VIPAS39 confers ferroptosis resistance in epithelial ovarian cancer through exporting ACSL4. Ebiomedicine. 114:1056462025. View Article : Google Scholar : PubMed/NCBI

Gao Y, Liu S, Huang Y, Wang H, Zhao Y, Cui X, Peng Y, Li F and Zhang Y: CAR T cells engineered to secrete IFNκ induce tumor ferroptosis via an IFNAR/STAT1/ACSL4 axis. Cancer Immunol Res. 12:1691–1702. 2024. View Article : Google Scholar : PubMed/NCBI

Liang Y and Zhao Y, Qi Z, Li X and Zhao Y: Ferroptosis: CD8+T cells' blade to destroy tumor cells or poison for self-destruction. Cell Death Discov. 11:1282025. View Article : Google Scholar : PubMed/NCBI

Xu S, Chaudhary O, Rodríguez-Morales P, Sun X, Chen D, Zappasodi R, Xu Z, Pinto AFM, Williams A, Schulze I, et al: Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8+ T cells in tumors. Immunity. 54:1561–1577.e7. 2021. View Article : Google Scholar : PubMed/NCBI

Ma X, Xiao L, Liu L, Ye L, Su P, Bi E, Wang Q, Yang M, Qian J and Yi Q: CD36-mediated ferroptosis dampens intratumoral CD8+ T cell effector function and impairs their antitumor ability. Cell Metab. 33:1001–1012.e5. 2021. View Article : Google Scholar : PubMed/NCBI

Zhao Z, Hu B, Deng Y, Soeung M, Yao J, Bei L, Zhang Y, Gong P, Huang LA, Jiang Z, et al: Sickle cell disease induces chromatin introversion and ferroptosis in CD8+ T cells to suppress anti-tumor immunity. Immunity. 58:1484–1501.e11. 2025. View Article : Google Scholar : PubMed/NCBI

Li S, Ouyang X, Sun H, Jin J, Chen Y, Li L, Wang Q, He Y, Wang J, Chen T, et al: DEPDC5 protects CD8+ T cells from ferroptosis by limiting mTORC1-mediated purine catabolism. Cell Discov. 10:532024. View Article : Google Scholar : PubMed/NCBI

Wang C, Wang X, Zhang D, Sun X, Wu Y, Wang J, Li Q and Jiang G: The macrophage polarization by miRNAs and its potential role in the treatment of tumor and inflammation (Review). Oncol Rep. 50:1902023. View Article : Google Scholar : PubMed/NCBI

Li H, Yang P, Wang J, Zhang J, Ma Q, Jiang Y, Wu Y, Han T and Xiang D: HLF regulates ferroptosis, development and chemoresistance of triple-negative breast cancer by activating tumor cell-macrophage crosstalk. J Hematol Oncol. 15:22022. View Article : Google Scholar : PubMed/NCBI

Luo X, Gong HB, Gao HY, Wu YP, Sun WY, Li ZQ, Wang G, Liu B, Liang L, Kurihara H, et al: Oxygenated phosphatidylethanolamine navigates phagocytosis of ferroptotic cells by interacting with TLR2. Cell Death Differ. 28:1971–1989. 2021. View Article : Google Scholar : PubMed/NCBI

Xiao L, Xian M, Zhang C, Guo Q and Yi Q: Lipid peroxidation of immune cells in cancer. Front Immunol. 14:13227462024. View Article : Google Scholar : PubMed/NCBI

Kapralov AA, Yang Q, Dar HH, Tyurina YY, Anthonymuthu TS, Kim R, St Croix CM, Mikulska-Ruminska K, Liu B, Shrivastava IH, et al: Redox lipid reprogramming commands susceptibility of macrophages and microglia to ferroptotic death. Nat Chem Biol. 16:278–290. 2020. View Article : Google Scholar : PubMed/NCBI

Hao X, Zheng Z, Liu H, Zhang Y, Kang J, Kong X, Rong D, Sun G, Sun G, Liu L, et al: Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing. Redox Biol. 56:1024632022. View Article : Google Scholar : PubMed/NCBI

Xiong H, Zhai Y, Meng Y, Wu Z, Qiu A, Cai Y, Wang G and Yang L: Acidosis activates breast cancer ferroptosis through ZFAND5/SLC3A2 signaling axis and elicits M1 macrophage polarization. Cancer Lett. 587:2167322024. View Article : Google Scholar : PubMed/NCBI

Huang WB, Lai HZ, Long J, Dai ZL, Ma Q, Xiao C and You FM: Biomechanics of the tumor extracellular matrix and regulatory T cells: Regulatory mechanisms and potential therapeutic targets. Cell Commun Signal. 23:3752025. View Article : Google Scholar : PubMed/NCBI

Wu Q, Carlos AR, Braza F, Bergman ML, Kitoko JZ, Bastos-Amador P, Cuadrado E, Martins R, Oliveira BS, Martins VC, et al: Ferritin heavy chain supports stability and function of the regulatory T cell lineage. EMBO J. 43:1445–1483. 2024. View Article : Google Scholar : PubMed/NCBI

Sumida TS, Cheru NT and Hafler DA: The regulation and differentiation of regulatory T cells and their dysfunction in autoimmune diseases. Nat Rev Immunol. 24:503–517. 2024. View Article : Google Scholar : PubMed/NCBI

Yan J, Zeng Y, Guan Z, Li Z, Luo S, Niu J, Zhao J, Gong H, Huang T, Li Z, et al: Inherent preference for polyunsaturated fatty acids instigates ferroptosis of Treg cells that aggravates high-fat-diet-related colitis. Cell Rep. 43:1146362024. View Article : Google Scholar : PubMed/NCBI

Xu C, Sun S, Johnson T, Qi R, Zhang S, Zhang J and Yang K: The glutathione peroxidase Gpx4 prevents lipid peroxidation and ferroptosis to sustain Treg cell activation and suppression of antitumor immunity. Cell Rep. 35:1092352021. View Article : Google Scholar : PubMed/NCBI

Wculek SK, Cueto FJ, Mujal AM, Melero I, Krummel MF and Sancho D: Dendritic cells in cancer immunology and immunotherapy. Nat Rev Immunol. 20:7–24. 2020. View Article : Google Scholar : PubMed/NCBI

Cubillos-Ruiz JR, Silberman PC, Rutkowski MR, Chopra S, Perales-Puchalt A, Song M, Zhang S, Bettigole SE, Gupta D, Holcomb K, et al: ER stress sensor XBP1 controls anti-tumor immunity by disrupting dendritic cell homeostasis. Cell. 161:1527–1538. 2015. View Article : Google Scholar : PubMed/NCBI

Qiu Y, Gan M, Wang X, Liao T, Chen Q, Lei Y, Chen L, Wang J, Zhao Y, Niu L, et al: The global perspective on peroxisome proliferator-activated receptor γ (PPARγ) in ectopic fat deposition: A review. Int J Biol Macromol. 253((Pt 5)): 1270422023. View Article : Google Scholar : PubMed/NCBI

Han L, Bai L, Qu C, Dai E, Liu J, Kang R, Zhou D, Tang D and Zhao Y: PPARG-mediated ferroptosis in dendritic cells limits antitumor immunity. Biochem Biophys Res Commun. 576:33–39. 2021. View Article : Google Scholar : PubMed/NCBI

Xiao K, Zhang S, Peng Q, Du Y, Yao X, Ng II and Tang H: PD-L1 protects tumor-associated dendritic cells from ferroptosis during immunogenic chemotherapy. Cell Rep. 43:1148682024. View Article : Google Scholar : PubMed/NCBI

Li JY, Ren C, Wang LX, Yao RQ, Dong N, Wu Y, Tian YP and Yao YM: Sestrin2 protects dendrite cells against ferroptosis induced by sepsis. Cell Death Dis. 12:8342021. View Article : Google Scholar : PubMed/NCBI

Li M, Jin S, Ma H, Yang X and Zhang Z: Reciprocal regulation between ferroptosis and STING-type I interferon pathway suppresses head and neck squamous cell carcinoma growth through dendritic cell maturation. Oncogene. 44:1922–1935. 2025. View Article : Google Scholar : PubMed/NCBI

Liu Y, Su C, Wei X, Wei N, Qian Q and Xu Z: Prospects and applications of NK therapy in the treatment of gliomas (Review). Oncol Rep. 54:882025. View Article : Google Scholar : PubMed/NCBI

Poznanski SM, Singh K, Ritchie TM, Aguiar JA, Fan IY, Portillo AL, Rojas EA, Vahedi F, El-Sayes A, Xing S, et al: Metabolic flexibility determines human NK cell functional fate in the tumor microenvironment. Cell Metab. 33:1205–1220.e5. 2021. View Article : Google Scholar : PubMed/NCBI

Chen T, Zhou S, Zhang Y, Meng H, Miao H, Feng M, Jiang Y, Wan Y, Zhang L and Cheng W: Overcoming ferroptosis-induced exhaustion of NK cells through inhibition of the ATF3-Mediated integrated stress response in ovarian cancer. Int J Biol Sci. 21:5531–5546. 2025. View Article : Google Scholar : PubMed/NCBI

Yao L, Hou J, Wu X, Lu Y, Jin Z, Yu Z, Yu B, Li J, Yang Z, Li C, et al: Cancer-associated fibroblasts impair the cytotoxic function of NK cells in gastric cancer by inducing ferroptosis via iron regulation. Redox Biol. 67:1029232023. View Article : Google Scholar : PubMed/NCBI

Pan B, Zhang X, Ye D, Yao Y, Zhang Z, Luo Y, Wu H, Wang X and Tang N: Intratumoral Brevibacillus parabrevis enhances antitumor immunity by inhibiting NK cell ferroptosis in hepatocellular carcinoma. Cell Death Dis. 16:4072025. View Article : Google Scholar : PubMed/NCBI

Dagher OK and Posey AD Jr: Forks in the road for CAR T and CAR NK cell cancer therapies. Nat Immunol. 24:1994–2007. 2023. View Article : Google Scholar : PubMed/NCBI

Wu L, Liu F, Yin L, Wang F, Shi H, Zhao Q, Yang F, Chen D, Dong X, Gu Y and Xing N: The establishment of polypeptide PSMA-targeted chimeric antigen receptor-engineered natural killer cells for castration-resistant prostate cancer and the induction of ferroptosis-related cell death. Cancer Commun (Lond). 42:768–783. 2022. View Article : Google Scholar : PubMed/NCBI

Tao B, Du R, Zhang X, Jia B, Gao Y, Zhao Y and Liu Y: Engineering CAR-NK cell derived exosome disguised nano-bombs for enhanced HER2 positive breast cancer brain metastasis therapy. J Control Release. 363:692–706. 2023. View Article : Google Scholar : PubMed/NCBI

Zhang F, Ma Y, Li D, Wei J, Chen K, Zhang E, Liu G, Chu X, Liu X, Liu W, et al: Cancer associated fibroblasts and metabolic reprogramming: unraveling the intricate crosstalk in tumor evolution. J Hematol Oncol. 17:802024. View Article : Google Scholar : PubMed/NCBI

Zhang K, Guo L, Li X, Hu Y and Luo N: Cancer-associated fibroblasts promote doxorubicin resistance in triple-negative breast cancer through enhancing ZFP64 histone lactylation to regulate ferroptosis. J Transl Med. 23:2472025. View Article : Google Scholar : PubMed/NCBI

Jiang F, Jia K, Chen Y, Ji C, Chong X, Li Z, Zhao F, Bai Y, Ge S, Gao J, et al: ANO1-Mediated inhibition of cancer ferroptosis confers immunotherapeutic resistance through recruiting cancer-associated fibroblasts. Adv Sci (Weinh). 10:e23008812023. View Article : Google Scholar : PubMed/NCBI

Zhao J, Shen J, Mao L, Yang T, Liu J and Hongbin S: Cancer associated fibroblast secreted miR-432-5p targets CHAC1 to inhibit ferroptosis and promote acquired chemoresistance in prostate cancer. Oncogene. 43:2104–2114. 2024. View Article : Google Scholar : PubMed/NCBI

Du J, Meng X, Yang M, Chen G, Li J, Zhu Z, Wu X, Hu W, Tian M, Li T, et al: NGR-Modified CAF-Derived exos targeting tumor vasculature to induce ferroptosis and overcome chemoresistance in osteosarcoma. Adv Sci (Weinh). 12:e24109182025. View Article : Google Scholar : PubMed/NCBI

Rottenberg S, Disler C and Perego P: The rediscovery of platinum-based cancer therapy. Nat Rev Cancer. 21:37–50. 2021. View Article : Google Scholar : PubMed/NCBI

Koeberle SC, Kipp AP, Stuppner H and Koeberle A: Ferroptosis-modulating small molecules for targeting drug-resistant cancer: Challenges and opportunities in manipulating redox signaling. Med Res Rev. 43:614–682. 2023. View Article : Google Scholar : PubMed/NCBI

Liu X, Yan C, Chang C, Meng F, Shen W, Wang S and Zhang Y: FOXA2 suppression by TRIM36 exerts anti-tumor role in colorectal cancer via inducing NRF2/GPX4-Regulated Ferroptosis. Adv Sci (Weinh). 10:e23045212023. View Article : Google Scholar : PubMed/NCBI

Xing P, Chen J, Hao H, Qiao X, Yang X, Weng K, Chen J, Song L, Liu T, Hou Y, et al: MTCH2 deficiency promotes E2F4/TFRC-Mediated ferroptosis and sensitizes colorectal cancer liver metastasis to sorafenib. Adv Sci (Weinh). 12:e000192025. View Article : Google Scholar : PubMed/NCBI

Song M, Huang S, Wu X, Zhao Z, Liu X, Wu C, Wang M, Gao J, Ke Z, Ma X and He W: UBR5 mediates colorectal cancer chemoresistance by attenuating ferroptosis via Lys 11 ubiquitin-dependent stabilization of Smad3-SLC7A11 signaling. Redox Biol. 76:1033492024. View Article : Google Scholar : PubMed/NCBI

Xin Z, Hu C, Zhang C, Liu M, Li J, Sun X, Hu Y, Liu X and Wang K: LncRNA-HMG incites colorectal cancer cells to chemoresistance via repressing p53-mediated ferroptosis. Redox Biol. 77:1033622024. View Article : Google Scholar : PubMed/NCBI

Qiu L, Li W, Zhang L, Zhang X, Zhao H, Miyagishi M, Wu S and Kasim V: p52-ZER6/DAZAP1 axis promotes ferroptosis resistance and colorectal cancer progression via regulating SLC7A11 mRNA stabilization. Acta Pharm Sin B. 15:2039–2058. 2025. View Article : Google Scholar : PubMed/NCBI

Huo Z, Liu G and Li J: Recent research progress and clinical status of immunotherapy for colorectal cancer. J Adv Res. 82:729–750. 2026. View Article : Google Scholar : PubMed/NCBI

Lu Y, Xie X and Luo L: Ferroptosis crosstalk in anti-tumor immunotherapy: Molecular mechanisms, tumor microenvironment, application prospects. Apoptosis. 29:1914–1943. 2024. View Article : Google Scholar : PubMed/NCBI

Haoyue W, Kexiang S, Shan TW, Jiamin G, Luyun Y, Junkai W and Wanli D: Icariin promoted ferroptosis by activating mitochondrial dysfunction to inhibit colorectal cancer and synergistically enhanced the efficacy of PD-1 inhibitors. Phytomedicine. 136:1562242025. View Article : Google Scholar : PubMed/NCBI

Lv Y, Tang W, Xu Y, Chang W, Zhang Z, Lin Q, Ji M, Feng Q, He G and Xu J: Apolipoprotein L3 enhances CD8+ T cell antitumor immunity of colorectal cancer by promoting LDHA-mediated ferroptosis. Int J Biol Sci. 19:1284–1298. 2023. View Article : Google Scholar : PubMed/NCBI

Chen P, Li X, Zhang R, Liu S, Xiang Y, Zhang M, Chen X, Pan T, Yan L, Feng J, et al: Combinative treatment of β-elemene and cetuximab is sensitive to KRAS mutant colorectal cancer cells by inducing ferroptosis and inhibiting epithelial-mesenchymal transformation. Theranostics. 10:5107–5119. 2020. View Article : Google Scholar : PubMed/NCBI

Zheng H, Liu J, Cheng Q, Zhang Q, Zhang Y, Jiang L, Huang Y, Li W, Zhao Y, Chen G, et al: Targeted activation of ferroptosis in colorectal cancer via LGR4 targeting overcomes acquired drug resistance. Nat Cancer. 5:572–589. 2024. View Article : Google Scholar : PubMed/NCBI

Gu Y, Wang Z and Wang Y: Bispecific antibody drug conjugates: Making 1+1>2. Acta Pharm Sin B. 14:1965–1986. 2024. View Article : Google Scholar : PubMed/NCBI

Zhang Y, Du J, Cui X, Ling Y and Tang C: Development of a bispecific CDH17-GUCY2C ADC bearing the ferroptosis inducer RSL3 for the treatment of colorectal cancer. Cell Death Discov. 11:3472025. View Article : Google Scholar : PubMed/NCBI

Ouladan S and Orouji E: Chimeric antigen receptor-T cells in colorectal cancer: Pioneering new avenues in solid tumor immunotherapy. J Clin Oncol. 43:994–1005. 2025. View Article : Google Scholar : PubMed/NCBI

Li D, Zhang W, Wang R, Xie S, Wang Y, Guo W, Huang Z, Lu C, Shan L, Liu H, et al: ROR1 CAR-T cells and ferroptosis inducers orchestrate tumor ferroptosis via PC-PUFA2. Biomark Res. 13:172025. View Article : Google Scholar : PubMed/NCBI

Chen S, Fan J, Xie P, Ahn J, Fernandez M, Billingham LK, Miska J, Wu JD, Wainwright DA, Fang D, et al: CD8+ T cells sustain antitumor response by mediating crosstalk between adenosine A2A receptor and glutathione/GPX4. J Clin Invest. 134:e1700712024. View Article : Google Scholar : PubMed/NCBI

Wong CC and Yu J: Gut microbiota in colorectal cancer development and therapy. Nat Rev Clin Oncol. 20:429–452. 2023. View Article : Google Scholar : PubMed/NCBI

Chen Y, Zhang Y, Dai M, Qiu C, Sun Q, Fan T, Guo Y, Zhao L and Jiang Y: γ-Linolenic acid derived from Lactobacillus plantarum MM89 induces ferroptosis in colorectal cancer. Food Funct. 16:1760–1771. 2025. View Article : Google Scholar : PubMed/NCBI

Li B, Wei Z, Wang Z, Xu F, Yang J, Lin B, Chen Y, Wenren H, Wu L, Guo X, et al: Fusobacterium nucleatum induces oxaliplatin resistance by inhibiting ferroptosis through E-cadherin/β-catenin/GPX4 axis in colorectal cancer. Free Radical Bio Med. 220:125–138. 2024. View Article : Google Scholar : PubMed/NCBI

Liu R, Wang J, Liu Y, Gao Y and Yang R: Regulation of gut microbiota on immune cell ferroptosis: A novel insight for immunotherapy against tumor. Cancer Lett. 598:2171152024. View Article : Google Scholar : PubMed/NCBI

Cui W, Guo M, Liu D, Xiao P, Yang C, Huang H, Liang C, Yang Y, Fu X, Zhang Y, et al: Gut microbial metabolite facilitates colorectal cancer development via ferroptosis inhibition. Nat Cell Biol. 26:124–137. 2024. View Article : Google Scholar : PubMed/NCBI

Zhou J, Lu P, He H, Zhang R, Yang D, Liu Q, Liu Q, Liu M and Zhang G: The metabolites of gut microbiota: Their role in ferroptosis in inflammatory bowel disease. Eur J Med Res. 30:2482025. View Article : Google Scholar : PubMed/NCBI

Zhou H, Zhuang Y, Liang Y, Chen H, Qiu W, Xu H and Zhou H: Curcumin exerts anti-tumor activity in colorectal cancer via gut microbiota-mediated CD8+ T Cell tumor infiltration and ferroptosis. Food Funct. 16:3671–3693. 2025. View Article : Google Scholar : PubMed/NCBI

O'Keefe SJ: Diet, microorganisms and their metabolites, and colon cancer. Nat Rev Gastroenterol Hepatol. 13:691–706. 2016. View Article : Google Scholar : PubMed/NCBI

Lin Y, Zhang Y, Huang T, Chen J, Li G, Zhang B, Xu L, Wang K, He H, Chen H, et al: Arginine deprivation induces quiescence and confers vulnerability to ferroptosis in colorectal cancer. Cancer Res. 85:1663–1679. 2025. View Article : Google Scholar : PubMed/NCBI

He Y, Ling Y, Zhang Z, Mertens RT, Cao Q, Xu X, Guo K, Shi Q, Zhang X, Huo L, et al: Butyrate reverses ferroptosis resistance in colorectal cancer by inducing c-Fos-dependent xCT suppression. Redox Biol. 65:1028222023. View Article : Google Scholar : PubMed/NCBI

Zhou X, Wang G, Wu Y, Wu M, Zhai X, Tian C, Prochownik EV, Jiang C and Li Y: SLC6A8-mediated creatine uptake suppresses ERK2-FSP1 signaling and induces ferroptosis in colorectal cancer. Cell Rep. 44:1161392025. View Article : Google Scholar : PubMed/NCBI

Liu Q, Zhao Y, Zhou H and Chen C: Ferroptosis: Challenges and opportunities for nanomaterials in cancer therapy. Regen Biomater. 10:rbad0042023. View Article : Google Scholar : PubMed/NCBI

Zhang Z, Ji Y, Hu N, Yu Q, Zhang X, Li J, Wu F, Xu H, Tang Q and Li X: Ferroptosis-induced anticancer effect of resveratrol with a biomimetic nano-delivery system in colorectal cancer treatment. Asian J Pharm Sci. 17:751–766. 2022.PubMed/NCBI

Wang H, Qiao C, Guan Q, Wei M and Li Z: Nanoparticle-mediated synergistic anticancer effect of ferroptosis and photodynamic therapy: Novel insights and perspectives. Asian J Pharm Sci. 18:1008292023.PubMed/NCBI

Luo J, Xu L, Feng J, Xu K, Tian P, Bai X, Xu S, Wen L, Lu C and Song J: Tumor microenvironment-activated and ROS-Augmented nanoplatform amplified PDT against colorectal cancer through impairing GPX4 to induce ferroptosis. ACS Appl Mater Interfaces. 17:41586–41596. 2025. View Article : Google Scholar : PubMed/NCBI

He M, Du C, Xia J, Zhang ZG and Dong CM: Multivalent polypeptide and tannic acid cooperatively iron-coordinated nanohybrids for synergistic cancer photothermal ferroptosis therapy. Biomacromolecules. 23:2655–2666. 2022. View Article : Google Scholar : PubMed/NCBI

Deng K, Tian H, Zhang T, Gao Y, Nice EC, Huang C, Xie N, Ye G and Zhou Y: Chemo-photothermal nanoplatform with diselenide as the key for ferroptosis in colorectal cancer. J Control Release. 366:684–693. 2024. View Article : Google Scholar : PubMed/NCBI

Yang H, Yao X, Liu Y, Shen X, Li M and Luo Z: Ferroptosis nanomedicine: Clinical challenges and opportunities for modulating tumor metabolic and immunological landscape. ACS Nano. 17:15328–15353. 2023. View Article : Google Scholar : PubMed/NCBI

Li Y, Duan Y, Li Y, Gu Y, Zhou L, Xiao Z, Yu X, Cai Y, Cheng E, Liu Q, et al: Cascade loop of ferroptosis induction and immunotherapy based on metal-phenolic networks for combined therapy of colorectal cancer. Exploration (Beijing). 5:202301172024. View Article : Google Scholar : PubMed/NCBI

McCoubrey LE, Favaron A, Awad A, Orlu M, Gaisford S and Basit AW: Colonic drug delivery: Formulating the next generation of colon-targeted therapeutics. J Control Release. 353:1107–1126. 2023. View Article : Google Scholar : PubMed/NCBI

Ye C, Mi M, Shi S, Qi L, Weng S, Wang L, Lu Y, Chen C, Tan Y, Yang M, et al: ROS-Responsive hydrogel for localized delivery of nampt and Stat3 inhibitors exhibits synergistic antitumor effects in colorectal cancer through ferroptosis induction and immune microenvironment remodeling. Adv Sci (Weinh). 12:e065992025. View Article : Google Scholar : PubMed/NCBI

Huang M, Wu Y, Wei X, Cheng L, Fu L, Yan H, Wei W, Li B, Ru H, Mo X, et al: Trifluridine/tipiracil induces ferroptosis by targeting p53 via the p53-SLC7A11 axis in colorectal cancer 3D organoids. Cell Death Dis. 16:2552025. View Article : Google Scholar : PubMed/NCBI

Wang Y, Qi D, Ge G, Cao N, Liu X, Zhu N, Li F, Huang X, Yu K, Zheng J, et al: WBP1 regulates mitochondrial function and ferroptosis to modulate chemoresistance in colorectal cancer. Mol Med. 31:932025. View Article : Google Scholar : PubMed/NCBI

Qian LH, Wen KL, Guo Y, Liao YN, Li MY, Li ZQ, Li SX and Nie HZ: Nutrient deficiency-induced downregulation of SNX1 inhibits ferroptosis through PPARs-ACSL1/4 axis in colorectal cancer. Apoptosis. 30:1391–1409. 2025. View Article : Google Scholar : PubMed/NCBI

Chen C, Yang Y, Guo Y, He J, Chen Z, Qiu S, Zhang Y, Ding H, Pan J and Pan Y: CYP1B1 inhibits ferroptosis and induces anti-PD-1 resistance by degrading ACSL4 in colorectal cancer. Cell Death Dis. 14:2712023. View Article : Google Scholar : PubMed/NCBI

Chen S, Ma J, Tang J, Yang Y, Zhou S and Feng P: Research progress of macrophage ferroptosis in inflammatory bowel disease and inflammation-cancer transformation. Front Immunol. 16:16582802025. View Article : Google Scholar : PubMed/NCBI

Zhang Y, Zhang Y, Yao S, Chen L, Dong Q, Luo R, Zheng K, Liu J, Liu Y, Chen Y, et al: Inflammatory bowel disease induces colorectal cancer: Risk factors, triggering mechanisms, and treatment with phyto-derivatives. Phytother Res. 39:3386–3418. 2025. View Article : Google Scholar : PubMed/NCBI

Iacucci M, Nardone OM, Ditonno I, Capobianco I, Pugliano CL, Maeda Y, Majumder S, Zammarchi I, Santacroce G and Ghosh S: Advancing inflammatory bowel disease-driven colorectal cancer management: Molecular insights and endoscopic breakthroughs towards precision medicine. Clin Gastroenterol Hepatol. 23:2361–2373. 2025. View Article : Google Scholar : PubMed/NCBI

Burgos-Molina AM, Téllez Santana T, Redondo M and Bravo Romero MJ: The Crucial role of inflammation and the immune system in colorectal cancer carcinogenesis: A comprehensive perspective. Int J Mol Sci. 25:61882024. View Article : Google Scholar : PubMed/NCBI

Liu Y, Zhang JT, Sun M, Song J, Sun HM, Wang MY, Wang CM and Liu W: Targeting ferroptosis in the treatment of ulcerative colitis by traditional Chinese medicine: A novel therapeutic strategies. Phytomedicine. 139:1565392025. View Article : Google Scholar : PubMed/NCBI

Zhang K, Guo J, Yan W and Xu L: Macrophage polarization in inflammatory bowel disease. Cell Commun Signal. 21:3672023. View Article : Google Scholar : PubMed/NCBI

Liang J, Wang N, Yao Y, Wang Y, An X, Wang H, Liu H, Jiang Y, Li H, Cheng X, et al: NEDD4L mediates intestinal epithelial cell ferroptosis to restrict inflammatory bowel diseases and colorectal tumorigenesis. J Clin Invest. 135:e1739942024. View Article : Google Scholar : PubMed/NCBI

Na YR, Stakenborg M, Seok SH and Matteoli G: Macrophages in intestinal inflammation and resolution: A potential therapeutic target in IBD. Nat Rev Gastroenterol Hepatol. 16:531–543. 2019. View Article : Google Scholar : PubMed/NCBI

Meng EX, Verne GN and Zhou Q: Macrophages and gut barrier function: Guardians of gastrointestinal health in post-inflammatory and post-infection responses. Int J Mol Sci. 25:94222024. View Article : Google Scholar : PubMed/NCBI

Tang B, Zhu J, Fang S, Wang Y, Vinothkumar R, Li M, Weng Q, Zheng L, Yang Y, Qiu R, et al: Pharmacological inhibition of MELK restricts ferroptosis and the inflammatory response in colitis and colitis-propelled carcinogenesis. Free Radic Biol Med. 172:312–329. 2021. View Article : Google Scholar : PubMed/NCBI

Kuang Z, Su Q, Liang W, Shen K and Xie J: PRSS22 inhibits HMOX1-mediated ferroptosis and induces osteopontin cleavage to promote M2 macrophage polarization and colitis-associated carcinogenesis. Oncogene. 45:1275–1286. 2026. View Article : Google Scholar : PubMed/NCBI

Wang S, Zhu L, Wang Y, Han Y, Wang Q, Yang W, Zhao L, Zhang Y, Pei D, Huang W, et al: ILF3 promotes colorectal cancer cell resistance to ferroptosis by enhancing cysteine uptake and GSH synthesis via stabilizing SLC3A2 mRNA. Cell Death Dis. 16:5492025. View Article : Google Scholar : PubMed/NCBI

Xiang Y, Zheng J, Zhao X, Zhou L, Yan Q, Ma Y, Zhou Y, Jiang P, Fang Y, Li W, et al: Sodium butyrate enhances sorafenib-induced ferroptosis and immunogenic cell death by modulating IRF2-Oasl2-cGAS pathway in colorectal cancer. Mater Today Bio. 35:1024982025. View Article : Google Scholar : PubMed/NCBI

Wang L, Wang J and Chen L: TIMP1 represses sorafenib-triggered ferroptosis in colorectal cancer cells by activating the PI3K/Akt signaling pathway. Immunopharmacol Immunotoxicol. 45:419–425. 2023. View Article : Google Scholar : PubMed/NCBI

Wang R, Xing R, Su Q, Yin H, Di Wu, Lv C and Yan Z: Knockdown of SFRS9 inhibits progression of colorectal cancer through triggering ferroptosis mediated by GPX4 Reduction. Front Oncol. 11:6835892021. View Article : Google Scholar : PubMed/NCBI

Jacobs SA, Lee JJ, George TJ, Wade JL III, Stella PJ, Wang D, Sama AR, Piette F, Pogue-Geile KL, Kim RS, et al: Neratinib-plus-cetuximab in quadruple-WT (KRAS, NRAS, BRAF, PIK3CA) metastatic colorectal cancer resistant to cetuximab or panitumumab: NSABP FC-7, A phase Ib study. Clin Cancer Res. 27:1612–1622. 2021. View Article : Google Scholar : PubMed/NCBI

Ren M, Jian Z, Li C, Cao J, Ma X, He L, Zhang Y, Chen Y and Xu Y: Design, synthesis, and in vitro/in vivo biological evaluation of Artesunate-Ebselen derivatives: GPX4-targeted ferroptosis induction and synergistic antitumor immune activation in colorectal cancer. Bioorg Chem. 174:1097552026. View Article : Google Scholar : PubMed/NCBI

Chen HC, Chen CY, Wang PY, Su PY, Tsai SP, Hsu CP, Liu HS, Huang CF, Cheng WH, Lee MF and Su CL: Using integrated bioinformatics analysis to identify saponin formosanin C as a ferroptosis inducer in colorectal cancer with p53 and oncogenic KRAS. Antioxidants (Basel). 14:10272025. View Article : Google Scholar : PubMed/NCBI

Niu X, Wang M, Wang M, Liu X, Zhang Y, Zheng P, Zhang S, Liu T, Cao Z and Zhang C: Dracorhodin perochlorate sensitizes colorectal cancer to ferroptosis by activating HMOX1 and inhibiting the SLC7A11/GPX4 axis. Int Immunopharmacol. 158:1148272025. View Article : Google Scholar : PubMed/NCBI

Zeng L, Zhao W, Han T, Qing F, He Z, Zhao Q, Luo A, Hu P, Ding X and Zhang Z: Ropivacaine prompts ferroptosis to enhance the cisplatin-sensitivity of human colorectal cancer through SIRT1/Nrf2 signaling pathway. Chem Biol Interact. 400:1111632024. View Article : Google Scholar : PubMed/NCBI

Huang JY, Hsu TW, Chen YR and Kao SH: Rosmarinic acid potentiates cytotoxicity of cisplatin against colorectal cancer cells by enhancing apoptotic and ferroptosis. Life (Basel). 14:10172024.PubMed/NCBI

Zeng X, Sun L, Ling X, Jiang Y, Shen J, Liang L and Zhang X: Comprehensive analysis identifies novel targets of gemcitabine to improve chemotherapy treatment strategies for colorectal cancer. Front Endocrinol (Lausanne). 14:11705262023. View Article : Google Scholar : PubMed/NCBI

Zhang H, Song X, Zhao L, Wang C, Chen S, Wang Y, Zhang L, Xu F, Zhang H, Wang Q and Luo C: Singlet oxygen-precharged injectable hydrogel triggers ferroptosis and lactate metabolism reprogramming for enhanced colorectal cancer immunotherapy. J Nanobiotechnol. 24:1862026. View Article : Google Scholar

Xie P, Yang ST, Huang Y, Zeng C, Xin Q, Zeng G, Yang S, Xia P, Tang X and Tang K: Carbon nanoparticles-Fe(II) complex for efficient tumor inhibition with low toxicity by amplifying oxidative stress. ACS Appl Mater Interfaces. 12:29094–29102. 2020.PubMed/NCBI

Rochette L, Dogon G, Rigal E, Zeller M, Cottin Y and Vergely C: Lipid peroxidation and iron metabolism: Two corner stones in the homeostasis control of ferroptosis. Int J Mol Sci. 24:4492022. View Article : Google Scholar : PubMed/NCBI

Chen X, Comish PB, Tang D and Kang R: Characteristics and biomarkers of ferroptosis. Front Cell Dev Biol. 9:6371622021. View Article : Google Scholar : PubMed/NCBI

Matsuoka Y, Katsumata Y, Chu PS, Morikawa R, Nakamoto N, Iguchi K, Takahashi K, Kou T, Ito R, Taura K, et al: Monitoring ferroptosis in vivo: Iron-driven volatile oxidized lipids as breath biomarkers. Redox Biol. 86:1038582025. View Article : Google Scholar : PubMed/NCBI

Zhao YP, Liu JL, Wang S and Li X: Role of non-coding RNA-regulated ferroptosis in colorectal cancer. Cell Death Discov. 11:3152025. View Article : Google Scholar : PubMed/NCBI

Ge X, Xu J, He J, Wang J and Qian Y: Identification and functional characterization of prognosis-related ferroptosis-associated lncRNAs in colorectal cancer. Front Immunol. 16:15612102025. View Article : Google Scholar : PubMed/NCBI

Chu X, Li X, Zhang Y, Dang G, Miao Y, Xu W, Wang J, Zhang Z and Cheng S: Integrative single-cell analysis of human colorectal cancer reveals patient stratification with distinct immune evasion mechanisms. Nat Cancer. 5:1409–1426. 2024. View Article : Google Scholar : PubMed/NCBI

Wang Y, Wu N, Li J, Liang J, Zhou D, Cao Q, Li X and Jiang N: The interplay between autophagy and ferroptosis presents a novel conceptual therapeutic framework for neuroendocrine prostate cancer. Pharmacol Res. 203:1071622024. View Article : Google Scholar : PubMed/NCBI

Hu Q, Wei W, Wu D, Huang F, Li M, Li W, Yin J, Peng Y, Lu Y, Zhao Q and Liu L: Blockade of GCH1/BH4 axis activates ferritinophagy to mitigate the resistance of colorectal cancer to erastin-induced ferroptosis. Front Cell Dev Biol. 10:8103272022. View Article : Google Scholar : PubMed/NCBI

Ubellacker JM and Dixon SJ: Prospects for ferroptosis therapies in cancer. Nat Cancer. 6:1326–1336. 2025. View Article : Google Scholar : PubMed/NCBI

Yan YY, Zhou HM, Shang XG, Xu P, Tang XQ, Zheng XY, Yu LH, Li CT, Xie T and Lou JS: Dynamic regulators of ferroptosis: Post-translational modifications in ferroptotic cell death. Pharmacol Res. 217:1078152025. View Article : Google Scholar : PubMed/NCBI

Feng S, Rao Z, Zhang J, She X, Chen Y, Wan K, Li H, Zhao C, Feng Y, Wang G, et al: Inhibition of CARM1-Mediated methylation of ACSL4 promotes ferroptosis in colorectal cancer. Adv Sci (Weinh). 10:e23034842023. View Article : Google Scholar : PubMed/NCBI

Zhang S, Xiao Y, Xie Z, Liu S, Li J, He P, Lai Y, Yin Y, Lin H, Pan H and Fang C: Jianpi Huayu Jiedu Decoction prevents the progression of H. pylori and MNU-induced gastric precancerous lesions by inhibiting ferroptosis and remodeling linoleic acid metabolism. J Ethnopharmacol. 352:1202172025. View Article : Google Scholar : PubMed/NCBI

Luo G, Jiang X, Hu C, Li L, Yan L, Xiao G, Duo Y and Zhang X: Artificial intelligence-powered nanomedicine. Chem Soc Rev. 55:2070–2119. 2026. View Article : Google Scholar : PubMed/NCBI

Hou J, Karin M and Sun B: Targeting cancer-promoting inflammation - have anti-inflammatory therapies come of age? Nat Rev Clin Oncol. 18:261–279. 2021. View Article : Google Scholar : PubMed/NCBI

Escuder-Rodríguez JJ, Liang D, Jiang X and Sinicrope FA: Ferroptosis: Biology and role in gastrointestinal disease. Gastroenterology. 167:231–249. 2024. View Article : Google Scholar : PubMed/NCBI

Zhu J, Zhang J, Lou Y, Zheng Y, Zheng X, Cen W, Ye L and Zhang Q: Developing a machine learning-based prognosis and immunotherapeutic response signature in colorectal cancer: insights from ferroptosis, fatty acid dynamics, and the tumor microenvironment. Front Immunol. 15:14164432024. View Article : Google Scholar : PubMed/NCBI

Wei X, Jiang Y, Chenwu F, Li Z, Wan J, Li Z, Zhang L, Wang J and Song M: Synergistic ferroptosis-immunotherapy nanoplatforms: Multidimensional engineering for tumor microenvironment remodeling and therapeutic optimization. Nanomicro Lett. 18:562025.PubMed/NCBI